Girardi v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedJanuary 4, 2021
Docket17-181
StatusUnpublished

This text of Girardi v. Secretary of Health and Human Services (Girardi v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Girardi v. Secretary of Health and Human Services, (uscfc 2021).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-181V Filed: December 7, 2020

* * * * * * * * * * * * * * * NICOLE GIRARDI, * UNPUBLISHED * Petitioner, * v. * Decision on Interim Attorneys’ Fees and * Costs SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * *

Mark Sadaka, Esq., Mark T. Sadaka, LLC, Englewood, NJ, for petitioner. Heather Pearlman, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On February 7, 2017, Angela and Joseph Girardi filed a petition for compensation under the National Vaccine Injury Compensation Program2 on behalf of their then-minor daughter, Nicole Girardi (“Ms. Girardi,” or “petitioner”). See Petition, ECF No. 1; Amended Petition, ECF No. 10. Petitioner alleges that she developed optic neuritis as a result of receiving a human papillomavirus (“HPV”) vaccination on March 20, 2014. Petition (“Pet.”), ECF No. 1. Petitioner now seeks an award of interim attorneys’ fees and costs. Petitioner’s Motion is hereby GRANTED.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107- 347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). I. Procedural History

The petition was filed on February 7, 2017; an Amended Petition was filed on February 10, 2017. ECF Nos. 1, 10. Petitioner filed medical records through July of 2017. See Pet. Ex. 1- 10, ECF No. 16; Pet. Ex. 11, ECF No. 17; Pet. Ex. 12, ECF No. 18; Pet. Ex. 13, ECF No. 20.

Respondent filed his Rule 4(c) Report (“Resp. Rpt.”) on October 20, 2017, recommending against compensation in this matter. ECF No. 25. Respondent submitted that “the record fail[ed] to establish a causal connection between petitioner’s HPV vaccine and her optic neuritis.” Resp. Rpt. at 6. An Order was issued for petitioner to file an expert report in support of her claim. Non- PDF Order, issued Oct. 20, 2017.

After requesting and receiving two extensions of time, petitioner filed an expert report from Dr. Steinman, along with supporting medical literature, on March 21, 2018. See Motion, ECF No. 26; Non-PDF Order, issued Jan. 16, 2018; Motion, ECF No. 27; Non-PDF Order, issued Mar. 15, 2018; Pet. Ex. 15-40, ECF No. 28.

Respondent filed expert reports from Dr. Lotz, a neurologist, and Dr. Whitton, an immunologist, on September 19, 2018. Resp. Ex. A-B, ECF No. 31; Resp. Ex. C-D, ECF No. 32.

A status conference was held on December 7, 2018, during which the expert reports were discussed. Scheduling Order at 1-2, ECF No. 33. It was noted that, although petitioner submits that she still suffers from a blind spot in her vision, all of her other symptoms had resolved by August 2014, approximately four months after onset. Id. at 1. Dr. Lotz opined that any observable blind spot is petitioner’s natural blind spot and not a consequence of her optic neuritis. Id. at 2. Petitioner was offered the opportunity to submit a report from her treating ophthalmologist on the issue of the blind spot. Id. It was also noted that some of petitioner’s medical records appeared to be missing pages. Id. Petitioner was ordered to file complete records and a supplemental report from Dr. Steinman by March 7, 2019. Id.

On March 7, 2019, petitioner filed the missing medical records. See Pet. Ex. 9, 14, ECF No. 37. Petitioner requested and received two extensions of time before filing a supplemental report and supporting medical literature from Dr. Steinman on July 3, 2019. See Motion, ECF No. 35; Non-PDF Order, issued Mar. 6, 2019; Motion, ECF No. 40; Non-PDF Order, issued June 3, 2019; Pet. Ex. 41, ECF No. 41; Pet. Ex. 42-47, ECF No. 42. Notably, petitioner has not addressed the issue of the ongoing blind spot and its relationship to optic neuritis, if any.

Respondent filed responsive expert reports from Dr. Lotz and Dr. Whitton on October 7, 2019. Resp. Ex. E, ECF No. 44; Resp. Ex. F, ECF No. 45.

A Rule 5 status conference was held on December 16, 2019. The expert reports were discussed in detail. Although Dr. Steinman and Dr. Lotz agreed that petitioner had optic neuritis, Dr. Lotz opined that petitioner’s headache 38 days post-vaccination was the onset of her optic neuritis and therefore too far out to be related to the HPV vaccine. Scheduling Order at 1, ECF No. 46. In response to this, Dr. Steinman pointed to a review of four case reports of neuromyelitis optica (“NMO”) occurring within months of quadrivalent HPV vaccination. Id. Dr. Lotz opined

2 that optic neuritis is mediated by a different neuroinflammatory process than NMO. Id. at 2. It was further noted that Dr. Steinman and Dr. Whitton disagree as to the significance of BLAST searches, upon which Dr. Steinman relies to support his theory of a molecular mimic between the HPV vaccine and myelin antigens that are attacked in optic neuritis. Id. Petitioner was ordered to submit a reasonable demand to respondent. Id. at 3. The parties were ordered to file a joint status report identifying potential hearing dates in March 2022. Id.

A prehearing order was issued on February 24, 2020, setting an entitlement hearing for March 7 and 8, 2022. ECF No. 49. Respondent filed a status report on April 2, 2020, advising that respondent would continue to defend this case. ECF No. 51.

On July 21, 2020, petitioner filed a Motion for Interim Attorneys’ Fees and Costs. Motion for Interim Fees, ECF No. 52. Petitioner requests attorneys’ fees in the amount of $37,764.69 and attorney costs in the amount of $19,006.96, for a total amount of $56,771.65. Motion for Interim Fees, Ex. A at 19-20.

On July 30, 2020, respondent filed a response to petitioner’s Motion for Fees. Response, ECF No. 53. Respondent “defer[ed] to the Special Master to determine whether or not petitioner has met the legal standard for an interim fees and costs award” as well as “whether there is a reasonable basis for the claim.” Id. at 2.

Petitioner filed a reply on July 31, 2020, reiterating her request for an award of interim fees. ECF No. 54.

This matter is now ripe for decision.

II. Applicable Law

The Vaccine Act permits an award of “reasonable attorneys’ fees” and “other costs.” § 15(e)(1). If a petition results in compensation, petitioner is entitled to reasonable attorneys’ fees and costs (“fees” or “fee award”). Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Avera v. Secretary of Health and Human Services
515 F.3d 1343 (Federal Circuit, 2008)
Hall v. Secretary of Health and Human Services
640 F.3d 1351 (Federal Circuit, 2011)
Sebelius v. Cloer
133 S. Ct. 1886 (Supreme Court, 2013)
Chuisano v. Secretary of Health and Human Services
116 Fed. Cl. 276 (Federal Claims, 2014)
Rehn v. Secretary of Health and Human Services
126 Fed. Cl. 86 (Federal Claims, 2016)
Raymo v. Secretary of Health and Human Services
129 Fed. Cl. 691 (Federal Claims, 2016)
Simmons v. Secretary of Health & Human Services
875 F.3d 632 (Federal Circuit, 2017)
Grice v. Secretary of Health & Human Services
36 Fed. Cl. 114 (Federal Claims, 1996)
Guy v. Secretary of Health & Human Services
38 Fed. Cl. 403 (Federal Claims, 1997)
McKellar v. Secretary of Health & Human Services
101 Fed. Cl. 297 (Federal Claims, 2011)
Broekelschen v. Secretary of Health & Human Services
102 Fed. Cl. 719 (Federal Claims, 2011)
Woods v. Secretary of Health & Human Services
105 Fed. Cl. 148 (Federal Claims, 2012)
Silva v. Secretary of Health & Human Services
108 Fed. Cl. 401 (Federal Claims, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Girardi v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/girardi-v-secretary-of-health-and-human-services-uscfc-2021.